Health-Chem Corporation
Health-Chem Corporation Fundamental Analysis
Health-Chem Corporation (HCLC) shows moderate financial fundamentals with a PE ratio of -0.00, profit margin of -27.88%, and ROE of 10.51%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 19.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HCLC's fundamental strength across five key dimensions:
Efficiency Score
WeakHCLC struggles to generate sufficient returns from assets.
Valuation Score
ExcellentHCLC trades at attractive valuation levels.
Growth Score
WeakHCLC faces weak or negative growth trends.
Financial Health Score
ModerateHCLC shows balanced financial health with some risks.
Profitability Score
WeakHCLC struggles to sustain strong margins.
Key Financial Metrics
Is HCLC Expensive or Cheap?
P/E Ratio
HCLC trades at -0.00 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HCLC's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Health-Chem Corporation at -0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.27 times EBITDA. This signals the market has high growth expectations.
How Well Does HCLC Make Money?
Net Profit Margin
For every $100 in sales, Health-Chem Corporation keeps $-27.88 as profit after all expenses.
Operating Margin
Core operations generate 44.51 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.51 in profit for every $100 of shareholder equity.
ROA
Health-Chem Corporation generates $-28.59 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Health-Chem Corporation generates limited operating cash flow of $30.71M, signaling weaker underlying cash strength.
Free Cash Flow
Health-Chem Corporation produces free cash flow of $22.56M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.03 in free cash annually.
FCF Yield
HCLC converts 4.72% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.00
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.01
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.46
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.20
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
-0.29
vs 25 benchmark
ROCE
Return on capital employed
-0.18
vs 25 benchmark
How HCLC Stacks Against Its Sector Peers
| Metric | HCLC Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.00 | 28.45 | Better (Cheaper) |
| ROE | 10.51% | 763.00% | Weak |
| Net Margin | -27.88% | -45265.00% (disorted) | Weak |
| Debt/Equity | -0.46 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 0.20 | 2795.60 | Weak Liquidity |
| ROA | -28.59% | -16588.00% (disorted) | Weak |
HCLC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Health-Chem Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation